Quantessence Capital LLC Eton Pharmaceuticals, Inc. Transaction History
Quantessence Capital LLC
- $400 Billion
- Q1 2025
A detailed history of Quantessence Capital LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantessence Capital LLC holds 16,590 shares of ETON stock, worth $335,781. This represents 0.05% of its overall portfolio holdings.
Number of Shares
16,590Holding current value
$335,781% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
88Shares Held
14MCall Options Held
61.2KPut Options Held
33.1K-
Opaleye Management Inc. Boston, MA2.85MShares$57.7 Million10.18% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.94MShares$39.3 Million1.98% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$23.8 Million0.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$22.3 Million0.0% of portfolio
-
Cannell Capital LLC Alta, WY691KShares$14 Million3.17% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $512M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...